Thu, May 27, 2021
Wed, May 26, 2021
Tue, May 25, 2021
Mon, May 24, 2021
Fri, May 21, 2021
Thu, May 20, 2021
Wed, May 19, 2021
Tue, May 18, 2021
Mon, May 17, 2021
Fri, May 14, 2021

Eliana Merle Initiated (ANAB) at Hold and Held Target at $29 on, May 21st, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-29-on-may-21st-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Eliana Merle of UBS, Initiated "AnaptysBio, Inc." (ANAB) at Hold and Held Target at $29 on, May 21st, 2021.

Eliana has made no other calls on ANAB in the last 4 months.



There are 3 other peers that have a rating on ANAB. Out of the 3 peers that are also analyzing ANAB, 1 agrees with Eliana's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Nierengarten of "Wedbush" Downgraded from Buy to Hold on, Tuesday, March 9th, 2021


These are the ratings of the 2 analyists that currently disagree with Eliana


  • Joon Lee of "Truist Securities" Upgraded from Hold to Strong Buy and Increased Target to $34 on, Tuesday, March 16th, 2021
  • Anupam Rama of "JP Morgan" Upgraded from Sell to Buy and Increased Target to $40 on, Thursday, February 11th, 2021

Publication Contributing Sources